Merck Unit Sues Sandoz Over Generic Noxafil
Merck & Co. Inc. subsidiary Schering Corp. lodged a suit Wednesday in New Jersey accusing Sandoz Inc. of infringing three patents by seeking to make and sell a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article